X-44873590-T-TGCC
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBS1BS2
The NM_001291415.2(KDM6A):c.48_50dupCGC(p.Ala17dup) variant causes a disruptive inframe insertion change. The variant allele was found at a frequency of 0.00113 in 1,203,989 control chromosomes in the GnomAD database, including 9 homozygotes. There are 352 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0058 ( 5 hom., 161 hem., cov: 23)
Exomes 𝑓: 0.00066 ( 4 hom. 191 hem. )
Consequence
KDM6A
NM_001291415.2 disruptive_inframe_insertion
NM_001291415.2 disruptive_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.02
Genes affected
KDM6A (HGNC:12637): (lysine demethylase 6A) This gene is located on the X chromosome and is the corresponding locus to a Y-linked gene which encodes a tetratricopeptide repeat (TPR) protein. The encoded protein of this gene contains a JmjC-domain and catalyzes the demethylation of tri/dimethylated histone H3. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Apr 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_001291415.2
BP6
Variant X-44873590-T-TGCC is Benign according to our data. Variant chrX-44873590-T-TGCC is described in ClinVar as [Likely_benign]. Clinvar id is 193446.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0058 (642/110759) while in subpopulation AFR AF= 0.0199 (605/30456). AF 95% confidence interval is 0.0186. There are 5 homozygotes in gnomad4. There are 161 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 5 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KDM6A | NM_001291415.2 | c.48_50dupCGC | p.Ala17dup | disruptive_inframe_insertion | 1/30 | ENST00000611820.5 | NP_001278344.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KDM6A | ENST00000611820.5 | c.48_50dupCGC | p.Ala17dup | disruptive_inframe_insertion | 1/30 | 1 | NM_001291415.2 | ENSP00000483595.2 |
Frequencies
GnomAD3 genomes AF: 0.00576 AC: 638AN: 110711Hom.: 5 Cov.: 23 AF XY: 0.00477 AC XY: 159AN XY: 33351
GnomAD3 genomes
AF:
AC:
638
AN:
110711
Hom.:
Cov.:
23
AF XY:
AC XY:
159
AN XY:
33351
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00151 AC: 249AN: 165211Hom.: 2 AF XY: 0.000860 AC XY: 50AN XY: 58141
GnomAD3 exomes
AF:
AC:
249
AN:
165211
Hom.:
AF XY:
AC XY:
50
AN XY:
58141
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000657 AC: 718AN: 1093230Hom.: 4 Cov.: 32 AF XY: 0.000530 AC XY: 191AN XY: 360198
GnomAD4 exome
AF:
AC:
718
AN:
1093230
Hom.:
Cov.:
32
AF XY:
AC XY:
191
AN XY:
360198
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00580 AC: 642AN: 110759Hom.: 5 Cov.: 23 AF XY: 0.00482 AC XY: 161AN XY: 33409
GnomAD4 genome
AF:
AC:
642
AN:
110759
Hom.:
Cov.:
23
AF XY:
AC XY:
161
AN XY:
33409
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:4
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 26, 2015 | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Dec 27, 2018 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 10, 2019 | - - |
Kabuki syndrome 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at